Contingency Management for Hoarding Disorder
Launched by HARTFORD HOSPITAL · May 17, 2021
Trial Information
Current as of October 01, 2025
Completed
Keywords
ClinConnect Summary
The primary aim of the current study is a preliminary investigation of the efficacy of contingency management (CM) in the treatment of hoarding disorder (HD). CM is a highly efficacious treatment that has been used to treat issues such as substance use disorders, medication/ medical regimen nonadherence, and schizophrenia. While the current best-practice treatment for HD (cognitive behavioral therapy; CBT) is efficacious in that it results in significant symptom reduction, many patients continue to have high levels of functional impairment and distressing symptoms after treatment completion...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with Primary Hoarding Disorder,
- • currently participating in the Hoarding Disorder treatment group at the HH Anxiety Disorders Center
- Exclusion Criteria:
- • Not clinically appropriate for a group treatment format (i.e., active suicidality or aggressive behavior, psychosis, current physiological substance dependence, or personality issues that would be expected to substantially interfere with the group milieu; cognitively intact).
- • Participants will also be excluded if they have previously completed CBT for HD.
- • In addition, participants in the CM portion of the treatment will be required to live within one hour travel time of the treatment facility to allow for home visits with the independent rater.
About Hartford Hospital
Hartford Hospital is a leading academic medical center affiliated with the University of Connecticut, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical research, the hospital focuses on a diverse range of therapeutic areas, aiming to improve patient outcomes and enhance treatment methodologies. With a robust infrastructure and a multidisciplinary team of experts, Hartford Hospital fosters a collaborative environment that supports the development and implementation of cutting-edge medical interventions, ultimately contributing to the advancement of medical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hartford, Connecticut, United States
Patients applied
Trial Officials
Blaise L Worden, Ph.D.
Principal Investigator
Hartford Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials